Conditioning Therapy
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL). (NCT01296256) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2011-05-01 |
Track Conditioning Therapy automatically
Every clearance here is in the API, with alerts when new ones post.